These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8016407)

  • 21. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism.
    Day HE; McKnight AT; Poat JA; Hughes J
    Neuropharmacology; 1994 Jun; 33(6):719-27. PubMed ID: 7936109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Devazepide alters meal patterns in lean, but not obese, male Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1994 Nov; 56(5):1037-9. PubMed ID: 7824568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H; Lauer G; Arnold R
    Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripherally and centrally administered bombesin induce Fos-like immunoreactivity in different brain regions in rats.
    Li BH; Rowland NE
    Regul Pept; 1996 Apr; 62(2-3):167-72. PubMed ID: 8795081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCK(A) and 5-HT3 receptors interact in anorectic responses to amino acid deficiency.
    Aja SM; Barrett JA; Gietzen DW
    Pharmacol Biochem Behav; 1999 Mar; 62(3):487-91. PubMed ID: 10080241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Smith GP; Tyrka A; Gibbs J
    Pharmacol Biochem Behav; 1991 Jan; 38(1):207-10. PubMed ID: 2017446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats.
    Woltman T; Castellanos D; Reidelberger R
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1420-33. PubMed ID: 8594945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCK antagonists and CCK-monoamine interactions in the control of satiety.
    Cooper SJ; Dourish CT; Clifton PG
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):291S-295S. PubMed ID: 1728842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718.
    Chen DY; Deutsch JA; Gonzalez MF; Gu Y
    Neurosci Lett; 1993 Jan; 149(1):91-4. PubMed ID: 7682304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent effects of CCK and devazepide in male and female rats.
    Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
    Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.
    Barrachina MD; Martínez V; Wang L; Wei JY; Taché Y
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10455-60. PubMed ID: 9294232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK.
    Becskei C; Grabler V; Edwards GL; Riediger T; Lutz TA
    Brain Res; 2007 Aug; 1162():76-84. PubMed ID: 17617389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1997 Sep; 62(3):545-50. PubMed ID: 9272662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fos expression in the brain induced by peripheral injection of CCK or leptin plus CCK in fasted lean mice.
    Wang L; Martínez V; Barrachina MD; Taché Y
    Brain Res; 1998 Apr; 791(1-2):157-66. PubMed ID: 9593872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
    Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
    Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.